当前位置: 首页 > 期刊 > 《健康必读·下旬刊》 > 2019年第10期
编号:13405428
疏血通注射液联合吡拉西坦注射液治疗头昏头痛的疗效分析
http://www.100md.com 2019年10月1日 《健康必读·下旬刊》 2019年第10期
     【摘 要】目的:分析头昏头痛患者,疏血通注射液联合吡拉西坦注射液静脉滴注的疗效。方法:选2017年5月到2018年6月在我院住院治疗的120例以“头昏头痛”为主诉的患者,对照组患者使用疏血通进行治疗。治疗组则在对照组的基础上,再使用吡拉西坦联合治疗头昏头痛。结果:治疗组总有效率为96.67%,对照组总有效率为70.00%。两组患者之间的差异具有统计学意义(P<0.05)。结论:对于头昏头痛患者使用吡拉西坦注射液联合疏血通注射液治疗,对于改善患者临床症状效果顯著,值得推广应用。

    【关键词】:疏血通;吡拉西坦;疗效分分析

    Abstract Objective: To analyze the effect of Shuxuetong injection combined with piracetam injection when the patient developed dizziness and headache.Methods: 120 patients with headache and dizziness who continued to be treated in our hospital from May 2017 to June 2018 were enrolled. The patients in the control group were treated with Shuxuetong . The treatment group was treated with piracetam in combination with headache and dizziness on the basis of the control group.Results: The total effective rate of the treatment group was 96.67% ......

您现在查看是摘要页,全文长 5517 字符